Skip to main content
Erschienen in: Irish Journal of Medical Science (1971 -) 3/2011

01.09.2011 | Original Article

The incidence and clinical correlates of lithium toxicity: a retrospective review

verfasst von: U. Dennison, M. Clarkson, J. O’Mullane, E. M. Cassidy

Erschienen in: Irish Journal of Medical Science (1971 -) | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Lithium is a commonly prescribed pharmacological treatment for mood disorders. It is associated with a number of side effects and potentially serious toxicity. To date, there is little data from Irish samples on the subject of Lithium toxicity.

Aim

To examine the incidence and clinical correlates of lithium toxicity in Cork, Ireland.

Results

Our study identified 130 cases of biochemical lithium toxicity over 5 years, with an incidence rate of approximately 5.4 cases per 100,000 per year. Mean toxic lithium level was 2.16 mmol/L ±SD 0.87 mmol/L. Of these, 36% cases were reviewed medically in the general hospital at the time of toxicity. A number of issues in relation to lithium toxicity were identified. Neurological symptoms were common, including tremor, confusion, ataxia, drowsiness. However, only 4.2% patients were reviewed by a neurologist while in hospital. Medications that interact with lithium were found in 50% cases, with significant polypharmacy in 15%. The psychiatric services were involved in patient care in 76% cases, and 85% patients presenting with toxicity were reviewed by a psychiatrist. Rates of admission to hospital and haemodialysis were 70 and 11%, respectively.

Conclusion

Improvements in the standards of care in relation to lithium prescribing are required.
Literatur
1.
Zurück zum Zitat Bauer M, Dopfmer S (1999) Lithium augmentation in treatment—resistant depression: a meta-analysis of placebo-controlled studies. J Clin Pharmacol 19:427–434 Bauer M, Dopfmer S (1999) Lithium augmentation in treatment—resistant depression: a meta-analysis of placebo-controlled studies. J Clin Pharmacol 19:427–434
2.
Zurück zum Zitat Baldessarini RJ, Tondo L, Davis P, Pompili M, Goodwin FK, Hennen J (2006) Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord 8:625–639PubMedCrossRef Baldessarini RJ, Tondo L, Davis P, Pompili M, Goodwin FK, Hennen J (2006) Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord 8:625–639PubMedCrossRef
3.
Zurück zum Zitat Cipriani A, Pretty H, Hawton K, Geddes J (2005) Lithium in the prevention of suicidal behaviour and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry 162(10):1805–1819PubMedCrossRef Cipriani A, Pretty H, Hawton K, Geddes J (2005) Lithium in the prevention of suicidal behaviour and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry 162(10):1805–1819PubMedCrossRef
4.
Zurück zum Zitat Moore GJ, Bebchuk JM, Hasanat K et al (2000) Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence of support of bcl-2’s neurotrophic effects? Biol Psychiatry 48:1–8PubMedCrossRef Moore GJ, Bebchuk JM, Hasanat K et al (2000) Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence of support of bcl-2’s neurotrophic effects? Biol Psychiatry 48:1–8PubMedCrossRef
5.
Zurück zum Zitat Nunes P, Forlenza O, Gattaz W (2007) Lithium and risk for Alzheimer’s in elderly patients with bipolar disorder. Br J Psychiatry 190:359–360PubMedCrossRef Nunes P, Forlenza O, Gattaz W (2007) Lithium and risk for Alzheimer’s in elderly patients with bipolar disorder. Br J Psychiatry 190:359–360PubMedCrossRef
6.
Zurück zum Zitat Goodwin G (1994) Recurrence of mania after lithium withdrawal: implications for the use of lithium in the treatment of bipolar affective disorder. Br J Psychiatry 164:149–152PubMedCrossRef Goodwin G (1994) Recurrence of mania after lithium withdrawal: implications for the use of lithium in the treatment of bipolar affective disorder. Br J Psychiatry 164:149–152PubMedCrossRef
7.
Zurück zum Zitat Johnson G (1998) Lithium-early development, toxicity, and renal function. Neuropsychopharmacology 19(3):200–205PubMedCrossRef Johnson G (1998) Lithium-early development, toxicity, and renal function. Neuropsychopharmacology 19(3):200–205PubMedCrossRef
8.
Zurück zum Zitat Müller-Oerlinghausen B, Felber W, Berghofer A, Lauterbach E, Ahrens B (2005) The impact of lithium long-term medication on suicidal behavior and mortality of bipolar patients. Arch Suicide Res 9(3):307–319PubMedCrossRef Müller-Oerlinghausen B, Felber W, Berghofer A, Lauterbach E, Ahrens B (2005) The impact of lithium long-term medication on suicidal behavior and mortality of bipolar patients. Arch Suicide Res 9(3):307–319PubMedCrossRef
9.
Zurück zum Zitat Gonzalez-Pinto A, Mosquera F, Alonso M et al. (2006) Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment. Bipolar Disord 8(5p2):618–624 Gonzalez-Pinto A, Mosquera F, Alonso M et al. (2006) Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment. Bipolar Disord 8(5p2):618–624
10.
Zurück zum Zitat Young A, Newham J (2006) Lithium in maintenance therapy for bipolar disorder. J Psychopharmacol 20:17–22PubMedCrossRef Young A, Newham J (2006) Lithium in maintenance therapy for bipolar disorder. J Psychopharmacol 20:17–22PubMedCrossRef
11.
Zurück zum Zitat Post R, Denicoff K, Leverich G et al (2003) Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. J Clin Psychiat 64(6):680CrossRef Post R, Denicoff K, Leverich G et al (2003) Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. J Clin Psychiat 64(6):680CrossRef
12.
Zurück zum Zitat Harris E, Barraclough B (1997) Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry 170(3):205PubMedCrossRef Harris E, Barraclough B (1997) Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry 170(3):205PubMedCrossRef
13.
Zurück zum Zitat Birch NJ, Groft P, Hullin R, Kehoe R (1993) Lithium prophylaxis: proposed guidelines for good clinical practice. Lithium 4(4):225–230 Birch NJ, Groft P, Hullin R, Kehoe R (1993) Lithium prophylaxis: proposed guidelines for good clinical practice. Lithium 4(4):225–230
15.
Zurück zum Zitat Amdisen A (1977) Serum level monitoring and clinical pharmacokinetics of lithium. Clin Pharmacokinet 2(2):73–92PubMedCrossRef Amdisen A (1977) Serum level monitoring and clinical pharmacokinetics of lithium. Clin Pharmacokinet 2(2):73–92PubMedCrossRef
16.
Zurück zum Zitat Sproule B (2002) Lithium in bipolar disorder: Can drug concentrations predict therapeutic effect? Clin Pharmacokinet 41(9):639–660PubMedCrossRef Sproule B (2002) Lithium in bipolar disorder: Can drug concentrations predict therapeutic effect? Clin Pharmacokinet 41(9):639–660PubMedCrossRef
17.
Zurück zum Zitat Coppen A, Abou-Saleh M, Milln P, Bailey J, Wood K (1983) Decreasing lithium dosage reduces morbidity and side-effects during prophylaxis. J Affect Disord 5(4):353–362PubMedCrossRef Coppen A, Abou-Saleh M, Milln P, Bailey J, Wood K (1983) Decreasing lithium dosage reduces morbidity and side-effects during prophylaxis. J Affect Disord 5(4):353–362PubMedCrossRef
18.
Zurück zum Zitat Alexander M, Farag Y, Mittal B, Rennke H, Singh A (2008) Lithium toxicity: a double-edged sword. Kidney Int 73(2):233–237PubMedCrossRef Alexander M, Farag Y, Mittal B, Rennke H, Singh A (2008) Lithium toxicity: a double-edged sword. Kidney Int 73(2):233–237PubMedCrossRef
19.
Zurück zum Zitat Eagles J, McCann I, Neil T, MacLeod N, Paterson N (2000) Lithium monitoring before and after the distribution of clinical practice guidelines. Acta Psychiatr Scand 101(5):349–353PubMedCrossRef Eagles J, McCann I, Neil T, MacLeod N, Paterson N (2000) Lithium monitoring before and after the distribution of clinical practice guidelines. Acta Psychiatr Scand 101(5):349–353PubMedCrossRef
20.
Zurück zum Zitat Hansen HE, Amdisen A (1978) Lithium intoxication. (Report of 23 cases and review of 100 cases from the literature). Q J Med 47(186):123–144PubMed Hansen HE, Amdisen A (1978) Lithium intoxication. (Report of 23 cases and review of 100 cases from the literature). Q J Med 47(186):123–144PubMed
21.
Zurück zum Zitat Petersen V, Hvidt S, Thomsen K, Schou M (1974) Effect of prolonged thiazide treatment on renal lithium clearance. Br Med J 3:143–145PubMedCrossRef Petersen V, Hvidt S, Thomsen K, Schou M (1974) Effect of prolonged thiazide treatment on renal lithium clearance. Br Med J 3:143–145PubMedCrossRef
22.
Zurück zum Zitat Finley P, O’Brien J, Coleman R (1996) Lithium and angiotensin-converting enzyme inhibitors: evaluation of a potential interaction. J Clin Psychopharm 16(1):68–71CrossRef Finley P, O’Brien J, Coleman R (1996) Lithium and angiotensin-converting enzyme inhibitors: evaluation of a potential interaction. J Clin Psychopharm 16(1):68–71CrossRef
23.
Zurück zum Zitat Ragheb M (1990) The clinical significance of lithium-nonsteroidal: anti-inflammatory drug interactions. J Clin Psychopharm 10(5):350–354CrossRef Ragheb M (1990) The clinical significance of lithium-nonsteroidal: anti-inflammatory drug interactions. J Clin Psychopharm 10(5):350–354CrossRef
24.
Zurück zum Zitat Apte SN, Langston JW (1983) Permanent neurological deficits due to lithium toxicity. Ann Neurol 13(4):453–455PubMedCrossRef Apte SN, Langston JW (1983) Permanent neurological deficits due to lithium toxicity. Ann Neurol 13(4):453–455PubMedCrossRef
25.
Zurück zum Zitat Nagaraja D, Taly A, Sahu R, Channabasavanna S, Narayanan H (1987) Permanent neurological sequelae due to lithium toxicity. Clin Neurol Neurosur 89(1):31–34CrossRef Nagaraja D, Taly A, Sahu R, Channabasavanna S, Narayanan H (1987) Permanent neurological sequelae due to lithium toxicity. Clin Neurol Neurosur 89(1):31–34CrossRef
26.
Zurück zum Zitat Gadallah MF, Feinstein EI, Massry SG (1988) Lithium intoxication: clinical course and therapeutic considerations. Miner Electrolyte Metab 14(2–3):146PubMed Gadallah MF, Feinstein EI, Massry SG (1988) Lithium intoxication: clinical course and therapeutic considerations. Miner Electrolyte Metab 14(2–3):146PubMed
Metadaten
Titel
The incidence and clinical correlates of lithium toxicity: a retrospective review
verfasst von
U. Dennison
M. Clarkson
J. O’Mullane
E. M. Cassidy
Publikationsdatum
01.09.2011
Verlag
Springer-Verlag
Erschienen in
Irish Journal of Medical Science (1971 -) / Ausgabe 3/2011
Print ISSN: 0021-1265
Elektronische ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-011-0712-6

Weitere Artikel der Ausgabe 3/2011

Irish Journal of Medical Science (1971 -) 3/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Chronisches Koronarsyndrom: Gefahr von Hospitalisierung wegen Herzinsuffizienz

06.05.2024 Herzinsuffizienz Nachrichten

Obwohl ein rezidivierender Herzinfarkt bei chronischem Koronarsyndrom wahrscheinlich die Hauptsorge sowohl der Patienten als auch der Ärzte ist, sind andere Ereignisse womöglich gefährlicher. Laut einer französischen Studie stellt eine Hospitalisation wegen Herzinsuffizienz eine größere Gefahr dar.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

„Restriktion auf vier Wochen Therapie bei Schlaflosigkeit ist absurd!“

06.05.2024 Insomnie Nachrichten

Chronische Insomnie als eigenständiges Krankheitsbild ernst nehmen und adäquat nach dem aktuellen Forschungsstand behandeln: Das forderte der Schlafmediziner Dr. Dieter Kunz von der Berliner Charité beim Praxis Update.

GLP-1-Rezeptoragonisten und SGLT-2-Hemmer: zusammen besser

06.05.2024 Typ-2-Diabetes Nachrichten

Immer häufiger wird ein Typ-2-Diabetes sowohl mit einem GLP-1-Rezeptor-Agonisten als auch mit einem SGLT-2-Inhibitor behandelt. Wie sich das verglichen mit den Einzeltherapien auf kardiovaskuläre und renale Komplikationen auswirkt, wurde anhand von Praxisdaten aus Großbritannien untersucht.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.